MarketPulse

combination therapy

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Boehringer Ingelheim, Zai Lab Partner on DLL3 Combo Therapy for Lung Cancer

Boehringer Ingelheim and Zai Lab collaborate on Phase Ib/II study combining T-cell engager obrixtamig with ADC zocilurtatug for small cell lung cancer treatment.
ZLABADC (antibody drug conjugate)immuno-oncology
GlobeNewswire Inc.GlobeNewswire Inc.··Spyre Therapeutics, Inc.

Spyre's SPY001 Shows Promise in Ulcerative Colitis With Strong SKYLINE Trial Data

Spyre Therapeutics reports positive Phase 2 results for SPY001 in ulcerative colitis, meeting primary endpoints with significant histopathology improvements and favorable safety.
SYREulcerative colitisclinical remission